Summer Sale
50% off Premium Yearly
NASDAQ:GNMK
GenMark Diagnostics (GNMK)
Financials 
Technical Analysis 
;fill-opacity:1;'/%3e%3cpath%20d='M31%2018.6001V30H8V18.6001L14.1334%2022.4334L19.4999%2014L24.8669%2022.4334L31%2018.6001Z'%20fill='%23EE5432'%20style='fill:%23EE5432;fill:color(display-p3%200.9340%200.3310%200.1956);fill-opacity:1;'/%3e%3c/svg%3e){kind=small}
Premium content- «
- ‹
- 1
- ›
- »
GenMark Diagnostics (GNMK) Frequently Asked Questions
What is GenMark Diagnostics stock symbol?
GenMark Diagnostics is a American stock, trading under the symbol GNMK (previously GNMK-Q on Stockchase) on the NASDAQ (GNMK). It is usually referred to as NASDAQ:GNMK or GNMK
Is GenMark Diagnostics a buy or a sell?
In the last year, no analyst issued a Buy, Sell, or Hold rating on GNMK (previously GNMK-Q on Stockchase) on Stockchase. Read the latest expert commentary for GenMark Diagnostics.
Is GenMark Diagnostics a good investment or a top pick?
GenMark Diagnostics was recommended as a Top Pick by The Panic-Proof Portfolio (Stockchase Research) on 2020-08-18. Read the latest stock experts ratings for GenMark Diagnostics.
Why is GenMark Diagnostics stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for GenMark Diagnostics.
Is GenMark Diagnostics worth watching?
GenMark Diagnostics is followed by 13 investors on Stockchase and is a trending stock that is worth watching.
What is GenMark Diagnostics stock price?
On 2021-04-21, GenMark Diagnostics (GNMK) stock closed at a price of $24.05.
(A Top Pick Aug 18/20, Down 18.6%) We chose to be disciplined and recommend exiting position as the $13.00 stop-loss was triggered last week. This follows the announcement by Abbott Labs for their successful emergency use authorization antibody test ahead of the GNMK proposal.